Tafluprost

As one of the most trusted Tafluprost API Manufacturers in India, we operate from state-of-the-art facilities that adhere to cGMP guidelines and international regulatory requirements. Our advanced synthesis processes, backed by experienced chemists and quality specialists, enable us to deliver APIs with exceptional purity and consistency. Being recognised among the leading Tafluprost API Manufacturers in Gujarat and Tafluprost API Manufacturers in Vadodara, we are committed to precision manufacturing, sustainable operations, and on-time delivery for both domestic and overseas clients.

In addition to manufacturing, Century Pharma is also a reliable Tafluprost API Trader in India, offering tailored supply solutions to meet varied client demands. Whether you require small quantities for research purposes or large-scale bulk supplies for commercial manufacturing, we provide flexible procurement options. Our strong network as a Tafluprost API Trader in Gujarat and Tafluprost API Trader in Vadodara ensures prompt delivery, complete regulatory documentation, and exceptional customer service at every stage of the process.

Choosing Century Pharma Ltd. as your trusted Tafluprost API Trader in Gujarat, India, means working with a company that values innovation, quality, and long-term client relationships. With decades of expertise in API manufacturing and trading, we remain a preferred choice for pharmaceutical companies worldwide seeking dependable, high-performance APIs for ophthalmic care. Our dedication to excellence ensures that every client receives products and services they can trust.


Global Presence

Century Pharma has established a robust global presence, delivering high-quality Active Pharmaceutical Ingredients (APIs) and services across key international markets. With strong footprints in Egypt, Vietnam, Mexico, Russia, Korea, and several MENA/GCC countries (Algeria, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, Kuwait, Lebanon, Libya, Mauritania, Morocco, Oman, Qatar, Saudi Arabia, Somalia, Sudan, Syria, Tunisia, the United Arab Emirates, and Yemen.), Century Pharma supports pharmaceutical advancements worldwide. Our expertise spans API manufacturing for human and animal health, enzyme production, biotechnology, and API research.

Additionally, Century Pharma excels in Contract API Manufacturing, Contract API Research, Method API Development, and Stability Studies, catering to regulatory and market-specific needs. As a trusted API manufacturer in India, Century Pharma continues to expand its global reach, fostering long-term collaborations and ensuring quality healthcare solutions across continents.

Contact today for support & solutions.








    Frequently Asked Questions

    Century Pharma Ltd. is a Tafluprost API manufacturer based in Vadodara, Gujarat, India. We welcome enquiries from pharmaceutical companies seeking bulk API sourcing. Contact our team with your required quantity, product specifications, and delivery destination.

    Pharmaceutical buyers can request information about the applicable Certificate of Analysis (COA) and product specifications. These documents help buyers evaluate API identity, purity, and batch quality. Contact Century Pharma to confirm document availability.

    The minimum order quantity depends on current availability, required quantity, and commercial terms. Share your expected purchase volume with Century Pharma to confirm MOQ, pricing, and delivery schedules.

    Century Pharma serves international pharmaceutical markets. Buyers can enquire about Tafluprost API export availability, quality documentation, and delivery arrangements. Supply is subject to applicable destination-country regulations and import requirements.

    To request a quotation, share your required quantity, product specifications, destination country, and expected delivery schedule. Century Pharma can review your enquiry and provide available commercial details.

    Buyers should review assay, identification, related substances, residual solvents, and applicable quality specifications. They should also verify stereochemical identity, degradation impurities, and stability data. These checks help manufacturers assess API quality and formulation suitability.

    Manufacturers should evaluate API purity, solubility, stability, degradation products, and compatibility with formulation ingredients. They should also review relevant microbial quality and endotoxin requirements. Finished ophthalmic products must meet applicable sterility and quality standards.

    Not necessarily. Tafluprost API intended for ophthalmic formulations is not automatically sterile. Buyers should confirm its sterility status, microbial specifications, and available quality documentation. They should also evaluate its suitability for the intended manufacturing and sterilisation processes.

    Tafluprost requires appropriate stability and storage controls. Buyers should review temperature requirements, degradation impurities, moisture sensitivity, and protective packaging. Product-specific stability data should guide storage and transport arrangements.

    International buyers should request applicable product specifications, batch COA, GMP evidence, stability information, and available regulatory support documents. They should also confirm import requirements and product-specific regulatory compliance in their destination market.

    Tafluprost API is the active pharmaceutical ingredient used to manufacture ophthalmic medicines. Preservative-free Tafluprost ophthalmic solution is a finished, sterile medicinal product containing Tafluprost and other formulation ingredients. Buyers should distinguish the raw API’s specifications from finished-product requirements such as sterility, pH, and packaging.

    WhatsApp
    Download Brochure